Evidence map›Paper›PMID 25980439›Full record

ArticleOncotarget2015

Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.

Mohammed Soutto, Judith Romero-Gallo, Uma Krishna, M Blanca Piazuelo, M Kay Washington, Abbes Belkhiri, Richard M Peek, Wael El-Rifai

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in cell and developmental biology · 2023
    Review
  7. TFF1 Induces Aggregation and Reduces Motility ofInternational journal of molecular sciences · 2021
    Article
  8. Molecular Alterations in the Stomach ofInternational journal of molecular sciences · 2020
    Article
  9. Article
  10. Article
  11. Binding ofMicroorganisms · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Gastric TFF1 Expression from Acute to ChronicFrontiers in cellular and infection microbiology · 2017
    Article
  17. Article
  18. Mouse models for gastric cancer: Matching models to biological questions.Journal of gastroenterology and hepatology · 2016
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mohammed SouttoDepartment of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.
Judith Romero-GalloDivision of Gastroenterology, Hepatology, & Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Uma KrishnaDivision of Gastroenterology, Hepatology, & Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
M Blanca PiazueloDivision of Gastroenterology, Hepatology, & Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
M Kay WashingtonDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abbes BelkhiriDepartment of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Richard M PeekDivision of Gastroenterology, Hepatology, & Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Wael El-RifaiDepartment of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · USVA Tennessee Valley Healthcare System · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2009 to 2026
$27.5M
Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pyloriP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1985 to 2019
$15.8M
H.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7M
Targets of Gene Overexpression at 17q in Gastric Tumorigenesis: Darpp32R01CA093999 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI EL-RIFAI, WAEL · 2002 to 2017
$4.5M
Molecular Pathobiology of Gastric CarcinogenesisI01BX001179 · VA · VETERANS HEALTH ADMINISTRATION · PI EL-RIFAI, WAEL · 2012 to 2024
–
BLRD VA I01 BX001179NCI NIH HHS P01 CA028842NCI NIH HHS P01 CA116087NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA68485NCI NIH HHS P50 CA095103NCI NIH HHS P50 CA95103NCI NIH HHS R01 CA077955NCI NIH HHS R01 CA093999NIDDK NIH HHS DK058404NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Using in vitro and in vivo models, we investigated the role of TFF1 in suppressing H. pylori-mediated activation of oncogenic β-catenin in gastric tumorigenesis. A reconstitution of TFF1 expression in gastric cancer cells decreased H. pylori-induced β-catenin nuclear translocation, as compared to control (p < 0.001). These cells exhibited significantly lower β-catenin transcriptional activity, measured by pTopFlash reporter, and induction of its target genes (CCND1 and c-MYC), as compared to control. Because of the role of AKT in regulating β-catenin, we performed Western blot analysis and demonstrated that TFF1 reconstitution abrogates H. pylori-induced p-AKT (Ser473), p-β-catenin (Ser552), c-MYC, and CCND1 protein levels. For in vivo validation, we utilized the Tff1-KO gastric neoplasm mouse model. Following infection with PMSS1 H. pylori strain, we detected an increase in the nuclear staining for β-catenin and Ki-67 with a significant induction in the levels of Ccnd1 and c-Myc in the stomach of the Tff1-KO, as compared to Tff1-WT mice (p < 0.05). Only 10% of uninfected Tff1-KO mice, as opposed to one-third of H. pylori-infected Tff1-KO mice, developed invasive adenocarcinoma (p = 0.03). These findings suggest that loss of TFF1 could be a critical step in promoting the H. pylori-mediated oncogenic activation of β-catenin and gastric tumorigenesis.

Indexed as

Active Transport, Cell NucleusAdenocarcinomaAnimalsbeta CateninCell Line, TumorCell ProliferationCell Transformation, NeoplasticDown-RegulationGastric MucosaGene Expression Regulation, NeoplasticHEK293 CellsHelicobacter InfectionsHelicobacter pyloriHost-Pathogen InteractionsHumansMice, Knockoutbeta CateninCTNNB1 protein, humanCTNNB1 protein, mousePeptidesRNA, MessengerTFF1 protein, humanTff1 protein, mouseTrefoil Factor-1Tumor Suppressor Proteinsgastric cancerHelicobacter pyloriß-cateninTFF1

Identifiers

PMID25980439
PMCPMC4627225
OpenAlexW2127321668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.